TWi Biotechnology, Inc.

NT$18.10As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6610Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (11.94%)
Div yield —
ROE (80.24%)
Biotechnology
Beta (5Y) 1.33
PE TTM —
TSR TTM (47.86%)
Mkt cap NT$3.721B
ROIC (59.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$22
21.77%
(38.50%)
Hold 4|8|1|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.23
0.24
0.25
0.24
1.41%
7.64%
15.04%
7.47%
RevenueNT$M
250.4
249.2
253.2
263.2
5.25%
2.39%
3.50%
10.70%
Peers (US$111.1M)
Cap (US$)
PE
116.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.476
0.137
0.116
EBIT/Intx
0.630
0.972
0.683
Own earn%
16.86
69.29
82.13
Sh yield%
38.92
36.02
37.64
Owners
Insiders/Inst%
14.13
51.85
Short interest%
2.32
SBC / revenue%
4.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
28–34
$1 testx
0.0
Incr. ROIC%
6